The IBEC is set to lead the coordination of the PHOTOTHERAPORT project, which will be developed with funding from the European Innovation Council’s Pathfinder Open programme. The project focuses on the development of luminescent implants and light-activated drugs for innovative neuromodulation therapies. PHOTOTHERAPORT will comprise an international consortium of 8 institutions and will receive €3 million over 3 years for the preclinical study of these implants.
A pioneering study led by IBEC in collaboration with ICFO has unveiled a method to control brain activity in living organisms using drugs activated by infrared light. This cutting-edge technique activates a specific neurotransmitter receptor using light that can penetrate deep into tissue and offers unparalleled pharmacological and spatiotemporal precision in three dimensions. The findings open new frontiers for neurobiology research and the development of light-based noninvasive neuromodulation therapies.
IBEC’s Core Facilities and nine of its research groups have undergone the “green laboratory” certification process granted by the My Green Lab organization, all awarded with the highest levels of … Read more
The Clinical Immersion Program for PhD students is an initiative Entrepreneurship Program of the IBEC and the College of Physicians of Barcelona (CoMB). Its objective is to connect IBEC doctoral … Read more
IBEC and the Eduard Soler Foundation have agreed to collaborate in the development of a prototype used to measure experimental data in a research project with molecules. The Eduard Soler … Read more
Researchers at the Institute for Bioengineering of Catalonia (IBEC) and the Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN) have achieved a nanoscale view of the electron transfer … Read more